Page last updated: 2024-09-03

astragaloside a and Adenocarcinoma of Lung

astragaloside a has been researched along with Adenocarcinoma of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, R; Chen, M; Li, G; Li, L	1

Other Studies

1 other study(ies) available for astragaloside a and Adenocarcinoma of Lung

Article	Year
Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy. Drug development research, 2022, Volume: 83, Issue:2 Topics: Adenocarcinoma of Lung; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bevacizumab; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Saponins; TOR Serine-Threonine Kinases; Triterpenes	2022

Article

Year

Astragaloside IV enhances the sensibility of lung adenocarcinoma cells to bevacizumab by inhibiting autophagy.

Drug development research, 2022, Volume: 83, Issue:2

Topics: Adenocarcinoma of Lung; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bevacizumab; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Saponins; TOR Serine-Threonine Kinases; Triterpenes

2022